Cysteinyl 1 Receptor Antagonist Montelukast, Does Not Prevent Peritoneal Membrane Damage in Experimental Chronic Peritoneal Dialysis Model in Rats
Background/Aims: Continuous ambulatory peritoneal dialysis (CAPD) induces structural changes in the peritoneal membrane such as fibrosis, vasculopathy and angioneogenesis with a reduction in ultrafiltration capacity. Leukotriene (LT) receptor antagonists have been found to be effective to prevent fi...
Main Authors: | Sibel Koçak Yucel, Hakki Arikan, Halil Tugtepe, Fulya Cakalagaoglu, Serhan Tuglular, Emel Akoglu, Cetin Ozener |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2014-12-01
|
Series: | Kidney & Blood Pressure Research |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/368477 |
Similar Items
-
Peritoneal dialysisrelated peritonitis with an unexpected micro-organism: enterococcus hirae
by: Dilek Barutcu Atas, et al.
Published: (2017-03-01) -
Peritoneal Dialysis-Associated Peritonitis
by: Funda TİMURKAYNAK
Published: (2006-09-01) -
The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
by: Hongjian Ye, et al.
Published: (2017-06-01) -
Peritonitis due to Candida Guilliermondii in a Patient on Continuous Ambulatory Peritoneal Dialysis
by: Emel Tatlı, et al.
Published: (2015-09-01) -
<i>Brucella</i> Peritonitis in a Patient on Peritoneal Dialysis
by: Alothman Adel, et al.
Published: (2008-01-01)